Resultats de la cerca - Jonathan Reuning‐Scherer

  • Mostrar 1 - 2 resultats de 2
Refinar resultats
  1. 1
    Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial

    Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial per Christopher Parker, Lin Zhan, Paul Cislo, Jonathan Reuning‐Scherer, Nicholas J. Vogelzang, Sten Nilsson, Oliver Sartor, Joe M. O’Sullivan, Robert E. Coleman

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study

    Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study per Sten Nilsson, Paul Cislo, Oliver Sartor, Nicholas J. Vogelzang, Robert E. Coleman, Joe M. O’Sullivan, Jonathan Reuning‐Scherer, Minghua Shan, Zhan Lu, Chris Parker

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: